Congress Asset Management Co. increased its holdings in Balchem Co. (NASDAQ:BCPC - Free Report) by 12.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 301,440 shares of the basic materials company's stock after purchasing an additional 33,373 shares during the quarter. Congress Asset Management Co. owned 0.93% of Balchem worth $53,053,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in BCPC. Allspring Global Investments Holdings LLC increased its stake in Balchem by 1.9% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 83,221 shares of the basic materials company's stock valued at $12,895,000 after buying an additional 1,553 shares during the period. Norden Group LLC acquired a new position in Balchem during the 1st quarter valued at $430,000. Commonwealth Equity Services LLC raised its stake in Balchem by 4.9% during the 1st quarter. Commonwealth Equity Services LLC now owns 14,722 shares of the basic materials company's stock valued at $2,281,000 after purchasing an additional 691 shares during the last quarter. BNP Paribas Financial Markets raised its stake in shares of Balchem by 21.8% in the 1st quarter. BNP Paribas Financial Markets now owns 37,117 shares of the basic materials company's stock valued at $5,751,000 after buying an additional 6,652 shares in the last quarter. Finally, Janney Montgomery Scott LLC raised its stake in shares of Balchem by 53.5% in the 1st quarter. Janney Montgomery Scott LLC now owns 2,977 shares of the basic materials company's stock valued at $461,000 after buying an additional 1,038 shares in the last quarter. Institutional investors and hedge funds own 87.91% of the company's stock.
Analyst Ratings Changes
BCPC has been the subject of a number of recent analyst reports. HC Wainwright increased their target price on shares of Balchem from $170.00 to $185.00 and gave the stock a "buy" rating in a research report on Wednesday, July 31st. StockNews.com raised shares of Balchem from a "hold" rating to a "buy" rating in a report on Monday.
Get Our Latest Stock Analysis on BCPC
Balchem Trading Down 0.9 %
Shares of NASDAQ BCPC traded down $1.55 during mid-day trading on Thursday, hitting $167.33. The company's stock had a trading volume of 94,888 shares, compared to its average volume of 106,994. The stock has a market cap of $5.43 billion, a price-to-earnings ratio of 47.32, a price-to-earnings-growth ratio of 5.43 and a beta of 0.65. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.83 and a quick ratio of 1.79. Balchem Co. has a one year low of $114.97 and a one year high of $186.03. The company's fifty day simple moving average is $171.75 and its 200-day simple moving average is $162.75.
About Balchem
(
Free Report)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
See Also
Before you consider Balchem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.
While Balchem currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
